These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29237380)

  • 1. Viscosity Control of Protein Solution by Small Solutes: A Review.
    Hong T; Iwashita K; Shiraki K
    Curr Protein Pept Sci; 2018; 19(8):746-758. PubMed ID: 29237380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine and lysine reduce the high viscosity of serum albumin solutions for pharmaceutical injection.
    Inoue N; Takai E; Arakawa T; Shiraki K
    J Biosci Bioeng; 2014 May; 117(5):539-43. PubMed ID: 24268865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific decrease in solution viscosity of antibodies by arginine for therapeutic formulations.
    Inoue N; Takai E; Arakawa T; Shiraki K
    Mol Pharm; 2014 Jun; 11(6):1889-96. PubMed ID: 24689736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viscosity-Lowering Effect of Amino Acids and Salts on Highly Concentrated Solutions of Two IgG1 Monoclonal Antibodies.
    Wang S; Zhang N; Hu T; Dai W; Feng X; Zhang X; Qian F
    Mol Pharm; 2015 Dec; 12(12):4478-87. PubMed ID: 26528726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
    Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
    Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-protein interactions at high concentrations: Effects of ArgHCl and NaCl on the stability, viscosity and aggregation mechanisms of protein solution.
    Ye Y; Huo X; Yin Z
    Int J Pharm; 2021 May; 601():120535. PubMed ID: 33811966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of additives on the formation of protein aggregates and viscosity in concentrated protein solutions.
    Bauer KC; Suhm S; Wöll AK; Hubbuch J
    Int J Pharm; 2017 Jan; 516(1-2):82-90. PubMed ID: 27836754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
    Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
    MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrophobic salts markedly diminish viscosity of concentrated protein solutions.
    Du W; Klibanov AM
    Biotechnol Bioeng; 2011 Mar; 108(3):632-6. PubMed ID: 21246510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 2.
    Hu Y; Toth RT; Joshi SB; Esfandiary R; Middaugh CR; Volkin DB; Weis DD
    J Pharm Sci; 2020 Jan; 109(1):353-363. PubMed ID: 31195015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viscosity Analysis of Dual Variable Domain Immunoglobulin Protein Solutions: Role of Size, Electroviscous Effect and Protein-Protein Interactions.
    Raut AS; Kalonia DS
    Pharm Res; 2016 Jan; 33(1):155-66. PubMed ID: 26286186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution.
    Liu J; Nguyen MD; Andya JD; Shire SJ
    J Pharm Sci; 2005 Sep; 94(9):1928-40. PubMed ID: 16052543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly viscous antibody solutions are a consequence of network formation caused by domain-domain electrostatic complementarities: insights from coarse-grained simulations.
    Buck PM; Chaudhri A; Kumar S; Singh SK
    Mol Pharm; 2015 Jan; 12(1):127-39. PubMed ID: 25383990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of Aggregation, Coaggregation, and Liquid Droplet of Proteins Using Small Additives.
    Iwashita K; Mimura M; Shiraki K
    Curr Pharm Biotechnol; 2018; 19(12):946-955. PubMed ID: 30514188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine Learning Applied to Determine the Molecular Descriptors Responsible for the Viscosity Behavior of Concentrated Therapeutic Antibodies.
    Lai PK; Fernando A; Cloutier TK; Gokarn Y; Zhang J; Schwenger W; Chari R; Calero-Rubio C; Trout BL
    Mol Pharm; 2021 Mar; 18(3):1167-1175. PubMed ID: 33450157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observation of small cluster formation in concentrated monoclonal antibody solutions and its implications to solution viscosity.
    Yearley EJ; Godfrin PD; Perevozchikova T; Zhang H; Falus P; Porcar L; Nagao M; Curtis JE; Gawande P; Taing R; Zarraga IE; Wagner NJ; Liu Y
    Biophys J; 2014 Apr; 106(8):1763-70. PubMed ID: 24739175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Well Do Low- and High-Concentration Protein Interactions Predict Solution Viscosities of Monoclonal Antibodies?
    Woldeyes MA; Qi W; Razinkov VI; Furst EM; Roberts CJ
    J Pharm Sci; 2019 Jan; 108(1):142-154. PubMed ID: 30017887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Computations of Preferential Interaction Coefficients of IgG1 Monoclonal Antibodies with Sorbitol, Sucrose, and Trehalose and the Impact of These Excipients on Aggregation and Viscosity.
    Cloutier T; Sudrik C; Mody N; Sathish HA; Trout BL
    Mol Pharm; 2019 Aug; 16(8):3657-3664. PubMed ID: 31276620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Native Reversible Self-Association of a Monoclonal Antibody Mediated by Fab-Fab Interaction.
    Gentiluomo L; Roessner D; Streicher W; Mahapatra S; Harris P; Frieß W
    J Pharm Sci; 2020 Jan; 109(1):443-451. PubMed ID: 31563513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coarse-Grained Molecular Dynamics Simulations for Understanding the Impact of Short-Range Anisotropic Attractions on Structure and Viscosity of Concentrated Monoclonal Antibody Solutions.
    Chowdhury A; Bollinger JA; Dear BJ; Cheung JK; Johnston KP; Truskett TM
    Mol Pharm; 2020 May; 17(5):1748-1756. PubMed ID: 32101441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.